Maine
Mass Shooting In Maine Leaves 18 Dead, 13 Wounded
A mass shooting in Lewiston, Maine, leaves 18 dead and 13 wounded. Authorities in the state have launched a manhunt for suspect Robert Card.
‘NY Times’ Examines Alpo Martinez’s Double Life In Witness Protection
HipHopWired Featured Video Source: Hugh Brown / Getty Alpo Martinez has been dead for months and his story continues to get more interesting. A new article explores his double life as a member of the witness protection program. This week The New York Times printed an in depth piece that examined Albert “Alpo” Martinez’s life after being released from prison in 2015 after serving 35-year sentence for 14 counts of murder. He would be then relocated to Lewiston, Maine under the alias Abraham Rodriguez and worked as a construction worker. Writer Ali Watkins spoke to several individuals who knew him as an easy going fellow. “He was the nicest neighbor,” said Marissa Ritchey. “He was always polite, nice with the dog. You never would have thought anything. He was one of the decent ones. He’d...
Alpo Martinez Lived A Quiet Life As An Unassuming Construction Worker In Maine
HipHopWired Featured Video Source: YouTube / Youtube Even in his afterlife, Alpo’s name continues to ring bells. A new article details his low profile life in Maine under an alias. Recently The Sun Journal dug deeper into the Harlem, New York native’s second life in The Pine Tree State as a member of the witness protection program. Not only does the feature confirm that he was released from prison in 2015, but it also goes into depth about his day to day as Abraham Rodriguez. The news outlet reports that he held various jobs including as a Pepsi fulfillment center employee and most recently as a construction worker. The accounts from his neighbors show that while he didn’t share much he still had a love for the fast life. “He kept to himself a lot,” said Harold Hanlon, but “he’d do an...
US election: Republicans hold back Democrats, narrowing path to Senate control
The battle for power in the Senate tightened into Wednesday as Democrats picked up a seat in Colorado, but suffered a setback in Alabama, and Republicans held their own in high-profile races in South Carolina, Iowa, Texas and Kansas, dramatically narrowing the political map. Republicans fought to retain their Senate majority by turning back a surge of Democrats challenging allies of President Donald Trump, and the Democrats’ various paths to seizing control were growing more limited. With several contests still too early to call, and one Georgia race heading to a January runoff, the final verdict is expected to drag on. Democrats gained a seat when ex-Gov. John Hickenlooper ousted GOP Sen. Cory Gardner in Colorado, a must-win to flip the Senate, but couldn’t hold on in Alabama, where forme...
Gold rises on renewed US stimulus hope, dollar falls
Spot gold rose 0.3 percent to $1,910.56 an ounce at 3:37pm, New York time, after falling as much as 0.5 percent. Gold rose on renewed optimism for a preelection aid package in the U.S., while the dollar fell to a one-week low. House Speaker Nancy Pelosi said a bill for a compromise stimulus package is being written as she awaits a key phone call with Treasury Secretary Steven Mnuchin. Senate Majority Leader Mitch McConnell said his chamber would take up a comprehensive coronavirus package if an accord is struck. The Bloomberg Dollar Spot Index headed for the third straight decline. Pelosi said in a Bloomberg Television interview that while there are areas where more work is required to get a compromise, she was pleased with the Trump administration’s latest position on coronavirus testing ...
Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine
Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...
